Cancer detection in clinical practice and using blood‐based liquid biopsy: A retrospective audit of over 350 dogs

Abstract Background Guidelines‐driven screening protocols for early cancer detection in dogs are lacking, and cancer often is detected at advanced stages. Hypothesis/Objectives To examine how cancer typically is detected in dogs and whether the addition of a next‐generation sequencing‐based “liquid...

Full description

Bibliographic Details
Main Authors: Andi Flory, Lisa McLennan, Betsy Peet, Marissa Kroll, Deirdre Stuart, Devon Brown, Kathy Stuebner, Brenda Phillips, Brenda L. Coomber, J. Paul Woods, Mairin Miller, Chelsea D. Tripp, Amber Wolf‐Ringwall, Kristina M. Kruglyak, Angela L. McCleary‐Wheeler, Ashley Phelps‐Dunn, Lilian K. Wong, Chelsea D. Warren, Gina Brandstetter, Michelle C. Rosentel, Lauren R. DiMarzio, Allison L. O'Kell, Todd A. Cohen, Daniel S. Grosu, Jason Chibuk, Dana W. Y. Tsui, Ilya Chorny, Jill M. Rafalko
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.16616
_version_ 1797937999476948992
author Andi Flory
Lisa McLennan
Betsy Peet
Marissa Kroll
Deirdre Stuart
Devon Brown
Kathy Stuebner
Brenda Phillips
Brenda L. Coomber
J. Paul Woods
Mairin Miller
Chelsea D. Tripp
Amber Wolf‐Ringwall
Kristina M. Kruglyak
Angela L. McCleary‐Wheeler
Ashley Phelps‐Dunn
Lilian K. Wong
Chelsea D. Warren
Gina Brandstetter
Michelle C. Rosentel
Lauren R. DiMarzio
Allison L. O'Kell
Todd A. Cohen
Daniel S. Grosu
Jason Chibuk
Dana W. Y. Tsui
Ilya Chorny
Jill M. Rafalko
author_facet Andi Flory
Lisa McLennan
Betsy Peet
Marissa Kroll
Deirdre Stuart
Devon Brown
Kathy Stuebner
Brenda Phillips
Brenda L. Coomber
J. Paul Woods
Mairin Miller
Chelsea D. Tripp
Amber Wolf‐Ringwall
Kristina M. Kruglyak
Angela L. McCleary‐Wheeler
Ashley Phelps‐Dunn
Lilian K. Wong
Chelsea D. Warren
Gina Brandstetter
Michelle C. Rosentel
Lauren R. DiMarzio
Allison L. O'Kell
Todd A. Cohen
Daniel S. Grosu
Jason Chibuk
Dana W. Y. Tsui
Ilya Chorny
Jill M. Rafalko
author_sort Andi Flory
collection DOAJ
description Abstract Background Guidelines‐driven screening protocols for early cancer detection in dogs are lacking, and cancer often is detected at advanced stages. Hypothesis/Objectives To examine how cancer typically is detected in dogs and whether the addition of a next‐generation sequencing‐based “liquid biopsy” test to a wellness visit has the potential to enhance cancer detection. Animals Client‐owned dogs with definitive cancer diagnoses enrolled in a clinical validation study for a novel blood‐based multicancer early detection test. Methods Retrospective medical record review was performed to establish the history and presenting complaint that ultimately led to a definitive cancer diagnosis. Blood samples were subjected to DNA extraction, library preparation, and next‐generation sequencing. Sequencing data were analyzed using an internally developed bioinformatics pipeline to detect genomic alterations associated with the presence of cancer. Results In an unselected cohort of 359 cancer‐diagnosed dogs, 4% of cases were detected during a wellness visit, 8% were detected incidentally, and 88% were detected after the owner reported clinical signs suggestive of cancer. Liquid biopsy detected disease in 54.7% (95% confidence interval [CI], 49.5%‐59.8%) of patients, including 32% of dogs with early‐stage cancer, 48% of preclinical dogs, and 84% of dogs with advanced‐stage disease. Conclusions/Clinical Importance Most cases of cancer were diagnosed after the onset of clinical signs; only 4% of dogs had cancer detected using the current standard of care (i.e., wellness visit). Liquid biopsy has the potential to increase detection of cancer when added to a dog's wellness visit.
first_indexed 2024-04-10T18:54:04Z
format Article
id doaj.art-d371ca1a414843748846f7200db24ee1
institution Directory Open Access Journal
issn 0891-6640
1939-1676
language English
last_indexed 2024-04-10T18:54:04Z
publishDate 2023-01-01
publisher Wiley
record_format Article
series Journal of Veterinary Internal Medicine
spelling doaj.art-d371ca1a414843748846f7200db24ee12023-02-01T04:49:52ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762023-01-0137125826710.1111/jvim.16616Cancer detection in clinical practice and using blood‐based liquid biopsy: A retrospective audit of over 350 dogsAndi Flory0Lisa McLennan1Betsy Peet2Marissa Kroll3Deirdre Stuart4Devon Brown5Kathy Stuebner6Brenda Phillips7Brenda L. Coomber8J. Paul Woods9Mairin Miller10Chelsea D. Tripp11Amber Wolf‐Ringwall12Kristina M. Kruglyak13Angela L. McCleary‐Wheeler14Ashley Phelps‐Dunn15Lilian K. Wong16Chelsea D. Warren17Gina Brandstetter18Michelle C. Rosentel19Lauren R. DiMarzio20Allison L. O'Kell21Todd A. Cohen22Daniel S. Grosu23Jason Chibuk24Dana W. Y. Tsui25Ilya Chorny26Jill M. Rafalko27PetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USADepartment of Clinical Studies, Ontario Veterinary College University of Guelph Guelph Ontario CanadaBridge Animal Referral Center Edmonds Washington USAClinical Investigation Center University of Minnesota Saint Paul Minnesota USAVeterinary Specialty Hospital of San Diego San Diego California USADepartment of Biomedical Sciences, Ontario Veterinary College University of Guelph Guelph Ontario CanadaInstitute for Comparative Cancer Investigation at the Mona Campbell Centre for Animal Cancer, Ontario Veterinary College, University of Guelph Guelph Ontario CanadaVeterinary Specialty Hospital of North County San Marcos California USABridge Animal Referral Center Edmonds Washington USADepartment of Veterinary Clinical Sciences University of Minnesota, College of Veterinary Medicine Saint Paul Minnesota USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAPetDx, Inc La Jolla California USAAbstract Background Guidelines‐driven screening protocols for early cancer detection in dogs are lacking, and cancer often is detected at advanced stages. Hypothesis/Objectives To examine how cancer typically is detected in dogs and whether the addition of a next‐generation sequencing‐based “liquid biopsy” test to a wellness visit has the potential to enhance cancer detection. Animals Client‐owned dogs with definitive cancer diagnoses enrolled in a clinical validation study for a novel blood‐based multicancer early detection test. Methods Retrospective medical record review was performed to establish the history and presenting complaint that ultimately led to a definitive cancer diagnosis. Blood samples were subjected to DNA extraction, library preparation, and next‐generation sequencing. Sequencing data were analyzed using an internally developed bioinformatics pipeline to detect genomic alterations associated with the presence of cancer. Results In an unselected cohort of 359 cancer‐diagnosed dogs, 4% of cases were detected during a wellness visit, 8% were detected incidentally, and 88% were detected after the owner reported clinical signs suggestive of cancer. Liquid biopsy detected disease in 54.7% (95% confidence interval [CI], 49.5%‐59.8%) of patients, including 32% of dogs with early‐stage cancer, 48% of preclinical dogs, and 84% of dogs with advanced‐stage disease. Conclusions/Clinical Importance Most cases of cancer were diagnosed after the onset of clinical signs; only 4% of dogs had cancer detected using the current standard of care (i.e., wellness visit). Liquid biopsy has the potential to increase detection of cancer when added to a dog's wellness visit.https://doi.org/10.1111/jvim.16616cancer screeningclinical signsearly stageincidentalliquid biopsymulticancer early detection
spellingShingle Andi Flory
Lisa McLennan
Betsy Peet
Marissa Kroll
Deirdre Stuart
Devon Brown
Kathy Stuebner
Brenda Phillips
Brenda L. Coomber
J. Paul Woods
Mairin Miller
Chelsea D. Tripp
Amber Wolf‐Ringwall
Kristina M. Kruglyak
Angela L. McCleary‐Wheeler
Ashley Phelps‐Dunn
Lilian K. Wong
Chelsea D. Warren
Gina Brandstetter
Michelle C. Rosentel
Lauren R. DiMarzio
Allison L. O'Kell
Todd A. Cohen
Daniel S. Grosu
Jason Chibuk
Dana W. Y. Tsui
Ilya Chorny
Jill M. Rafalko
Cancer detection in clinical practice and using blood‐based liquid biopsy: A retrospective audit of over 350 dogs
Journal of Veterinary Internal Medicine
cancer screening
clinical signs
early stage
incidental
liquid biopsy
multicancer early detection
title Cancer detection in clinical practice and using blood‐based liquid biopsy: A retrospective audit of over 350 dogs
title_full Cancer detection in clinical practice and using blood‐based liquid biopsy: A retrospective audit of over 350 dogs
title_fullStr Cancer detection in clinical practice and using blood‐based liquid biopsy: A retrospective audit of over 350 dogs
title_full_unstemmed Cancer detection in clinical practice and using blood‐based liquid biopsy: A retrospective audit of over 350 dogs
title_short Cancer detection in clinical practice and using blood‐based liquid biopsy: A retrospective audit of over 350 dogs
title_sort cancer detection in clinical practice and using blood based liquid biopsy a retrospective audit of over 350 dogs
topic cancer screening
clinical signs
early stage
incidental
liquid biopsy
multicancer early detection
url https://doi.org/10.1111/jvim.16616
work_keys_str_mv AT andiflory cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT lisamclennan cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT betsypeet cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT marissakroll cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT deirdrestuart cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT devonbrown cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT kathystuebner cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT brendaphillips cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT brendalcoomber cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT jpaulwoods cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT mairinmiller cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT chelseadtripp cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT amberwolfringwall cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT kristinamkruglyak cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT angelalmcclearywheeler cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT ashleyphelpsdunn cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT liliankwong cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT chelseadwarren cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT ginabrandstetter cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT michellecrosentel cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT laurenrdimarzio cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT allisonlokell cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT toddacohen cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT danielsgrosu cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT jasonchibuk cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT danawytsui cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT ilyachorny cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs
AT jillmrafalko cancerdetectioninclinicalpracticeandusingbloodbasedliquidbiopsyaretrospectiveauditofover350dogs